Status and phase
Conditions
Treatments
About
This is a randomized controlled trial of testosterone replacement therapy in hypogonadal men age > 60 years. The goal is to assess the safety and efficacy of TRT in men age > 60 years.
Sex
Ages
Volunteers
Inclusion criteria
age 60-80 yrs serum total testosterone < 300 ng/dL serum bioavailable testosterone < 70 ng/dL
Exclusion criteria
unable to provide informed consent history of prostate or breast cancer untreated sleep apnea
Primary purpose
Allocation
Interventional model
Masking
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal